Search

everythinglearnresearchcommunity

for

Search:↓

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

Androgens may increase arrhythmias in Brugada Syndrome, while Finasteride could reduce them.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

The drug combination was safe and showed promise in treating advanced tumors.

The committee decided not to approve the drug due to low effectiveness and high risks.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

MR antagonists may improve skin health and wound healing, especially in aging.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

A new neural network helps identify key regulators in cell changes, aiding in understanding diseases and finding new treatments.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Thallium poisoning can be identified through radiological signs and treated effectively with B.A.L.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.